Monday, 22 April 2019

Evidence Supporting Niacin Use for CV Disease Prevention Evaluated

According to the results of a systematic review & meta-analysis, evidence supporting the clinical benefit of niacin monotherapy for secondary prevention of Cardiovascular Disease appears to be outdated and require various innovative trials to determine its role in CVD management.
Scientists performed a systematic review and meta-analysis to identify clinical trials assessing the effect of niacin on lipid modification and CVD risk To determine the role of niacin in CVD prevention.
Image result for monotherapy and heart
The results from the study shows that while there is evidence to support the clinical benefit of niacin in the prevention of CVD, this evidence was obtained from older trials with study populations that most likely have differing baseline characteristics (i.e., underlying cardiovascular risk) compared to patient populations seen today. The authors concluded that “Niacin may have a role as a monotherapy drug for lipid control in statin-intolerant patients, but, given substantial advancements in cardiovascular disease management since 1990, this indication should be restudied in current-day patients receiving usual baseline care.”

Wednesday, 20 March 2019

Scientists discover the missing link between Cardiovascular Disease and Depression

Heart disease is a common disease now a days which leads to death worldwide. On other hand Depression is the leading cause of disability worldwide.
A significant body of research has established a connection between these two conditions.
For example, reviews of existing studies have shown that people with cardiovascular disease are more likely to have depression, and people with depression have a higher risk of developing cardiovascular disease. Also, those with depression and heart disease are more likely to die from the latter than those who only have heart disease. This relationship is proportional to each other which means that the more severe the depression, the more likely it is that a person will develop heart disease or die from it.

The study revealed that three bio-markers for the risk of heart disease that were also depression risk factors: triglycerides and the inflammation-related proteins IL-6 and CRP.
The scientists explain that our bodies produce the inflammation proteins IL-6 and CRP in response to physiological factors such as infections and lifestyle factors such as smoking, drinking, and physical inactivity, as well as in response to psychological stress.
In the study, first researchers were interested to study whether the family history of coronary heart disease increases the risk for depression. Later on they wanted to study regarding the gene involvement in this case. They found no connection between the genetic predisposition to develop heart disease and the risk of depression. This concluded that the genetic predisposition is not related with the link between depression and heart disease.
To find out whether the environmental factors are making the difference for the development of both the disease conditions, they used statistical tools Mendelian Randomization to examine the 15 biological markers. This study revealed the association of 3 bio-markers which increases the risk for heart disease were also the depression factors i.e. triglycerides, IL-6 (inflammation related protein) and CRP.
Heart disease and depression share common underlying biological mechanisms, which manifest as two different conditions in two different organs — the cardiovascular system and the brain."

Tuesday, 8 January 2019

Abstract Submission for Cardiology Summit 2019

2nd Global Cardiology Summit is a interactive platform for all the researchers, professors, CEOs to express and present their research findings in Cardiology arena. Cardiology Summit 2019 is held this year in Bangkok, Thailand from August 15-16, 2019. Theme: Where the world of Cardiology and Health Care comes together.

We are open for abstract submissions. Interested presenters can submit the abstract for oral or poster presentation.

Please do submit the abstracts now!!!

Benefits for all the accepted abstracts: 
  • All the accepted abstracts are eligible for presentation either oral or poster. 
  • All the accepted abstracts will be provided with 10% discount on registration fare.
  • Accepted abstracts will be published in Journal of Clinical and Experimental Cardiology. 
  • Assigned with unique DOI number provided by Crossref.

Thursday, 8 November 2018

Cardiology Summit 2019 announcement


After the completion of the Global Cardiology Summit, we are glad to inform the commencement of next event in the series as 2nd #Global Cardiology Summit scheduled to be held at Bangkok, Thailand, May 13-14, 2019. 
Theme: Where the world of Cardiology and Healthcare comes together

The categories of the conference are
  • Keynote Presentations
  • Oral and Poster Sessions
  • Workshops and Symposia
  • Exhibitions
  • Delegate Participation

We are now open for abstract submissions for Oral as well as Poster sessions. Kindly do submit the abstracts and get registered at to reserve early slots and save money on registration fare. 

For submitting the abstract follow the link:

The conference brochure now available online at

Interested delegate participants can register now and avail Early Bird Prices. 

Registration Link to register with early bird prices: 

***We have incorporated special registration privilege for all Thailand citizens. All interested local citizens of Thailand can make use of it and reserve these few slots:

To know more on  about Cardiology Summit 2019,  download the conference brochure @

Group of more than 5 attendees can avail Group Discounts. To know more mail us at

Saturday, 29 September 2018

World Heart Day

On the occasion of world heart day, we the team of Cardiology Summit 2018 wishes all "HAPPY WORLD HEART DAY"

Keep the heart in good condition through healthy diet, changes in the lifestyle and exercise. Keep the heart in safe mode and be healthy. 
The world heart day aims to reduce the Cardiovascular disease. 
Know more on advances in cardiac research and heart diseases at Cardiology Summit 2018 at Osaka, Japan.
Save the date: October 22-23, 2018.
Get registered through the link:

Friday, 21 September 2018

Countdown started!!!!

Global Cardiology Summit at Osaka, Japan from October 22-23, 2018.

Cardiology and Healthcare Professionals are invited to join this summit. 
27 days more to go for Cardiology Summit 2018
Only 1 days left for abstract submission. Submit your research

All accepted abstracts will be published in Journal of Clinical and Experimental Cardiology.

Please check out the Confirmed Keynote Speakers and Renowned Speakers at Cardiology Summit 2018:
  • Dr. David F. Kong, Co-Director, Duke Clinical Research Institute, USA.
  • Dr. Ehud Baron, Chairman and President, X-Cardio Corp. KK, Japan.
  • Ezzeldin Mostafa, Professor, Ain Shams University, Cairo, Egypt.
  • Dr. John Wang, Principal Scientist, Philips Healthcare, USA
  • Dr. Avinash Pawar, Senior Physician, D. Y. Patil Hospital, India.
  • Dr. Vanesa Gregorietti, Chairman and President, Cardiology Society of Buenos Aires, Argentina.
  • Dr. Shanmiao Lin, Director, Pediatric Cardiology, Mackay Memorial hospital, Taiwan.
and many more...

Important Links:
Abstract Submission: :

Deadline for Abstract Submission: September 25, 2018

Register before September 26, 2018 to avail Early Bird Registration discounts.

For further more queries, kindly reach us  at or

Tuesday, 18 September 2018

Cardiology Ethics and Case Reports

Track 19: 

Cardiology Ethics and Case Reports

Cardiology is one of the most dynamic and variable medical disciplines. In the era of evidence based medicine, progress in cardiology requires continuous inflow of scientific data that support new standards and newly-formulated hypotheses. As any other healthcare specialists, cardiologists are expected to adhere to highly standardized diagnostic and therapeutic guidelines that are developed by international consensus groups on the basis of evidence from large clinical trials. Management of cardiologic patients should be also based on the principles of professional morality expressed in internationally recognized documents such as Good Laboratory Practices and country-specific Codes of Medical Ethics. However, application of the ethical principles becomes highly challenging to a highly variable population of cardiologic patients including both pediatric and geriatric subjects. Cardiologic research should adhere to the same ethical principles as studies in any other discipline of clinical medicine
Each year 17.3 million people die of cardiovascular disease, 80% in the developing world. The case report in general is a short article which describes an interesting fact in medicine.  It may include a new medical condition, a new disease, a new diagnostic approach or a new therapeutic strategy. Case reports usually document episodes in the initial emerging phase or in a small outbreak.  These documental information becomes the basic for further case series, reviews and studies. The World Heart Federation exists to prevent and control these diseases through awareness and action, promoting the exchange of information, ideas and science among those involved in cardiovascular care, promoting for disease prevention and control by encouraging healthy diets, physical activity and tobacco free living at an individual, community and policy maker level. Cardiology conference is a suitable platform to uncover various developments and case studies in the field of cardiology.

Cardiology Ethics and Case Reports

Case Reports and ethical issues in cardiology related abstracts can be submitted through the link:
Abstract Submission closes on September 25, 2018. 

Submit the abstract, present it and get published in our cardiology journals. 

Delegates can register through the link:

Group Sponsorship details can be discussed with the program coordinator, at


Evidence Supporting Niacin Use for CV Disease Prevention Evaluated

According to the results of a systematic review & meta-analysis, evidence supporting the clinical benefit of niacin monotherapy for se...

Announcement: Cardiology Summit 2018